Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02340364 · ClinicalTrials.gov registry record · NA

Patient NAVIgation to Reduce Readmissions Among Black Men With Heart Disease

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
301
Enrollment target

NCT02340364 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 301 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02340364, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
301 participants
Enrollment target

Study Summary

The investigators are asking subjects to take part in the Patient NAVIgation to Reduce Readmissions among Black Men with Heart Disease (NAVI-HF) research study. This research study will test how well trained laypeople working as patient navigators will help patients recently hospitalized for heart failure avoid future hospitalizations. NAVI-HF is a new program sponsored by funding from the National Institute of Minority Health and Health Disparities. People who enter into the study will work with a patient navigator to undergo the full program or work with a trained layperson to receive general education on heart disease treatment and prevention. The purpose of the study is to determine whether a patient navigation program will be effective in reducing the number of hospitalizations in the future for program participants. This study will enroll 416 participants from UAB.

Interventions

  • BEHAVIORAL Education + Patient Navigation
  • BEHAVIORAL Self-care Education

Trial Details

FieldValue
Enrollment Target 301 participants
Start Date 2015-03
Est. Completion 2019-07
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT02340364

The ClinicalTrials.gov registry entry for NCT02340364 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 301 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Education + Patient Navigation is the first listed.

NCT02340364 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02340364 about?

NCT02340364 is a clinical study titled "Patient NAVIgation to Reduce Readmissions Among Black Men With Heart Disease". The investigators are asking subjects to take part in the Patient NAVIgation to Reduce Readmissions among Black Men with Heart Disease (NAVI-HF) research study. This research study will test how well trained laypeople working as patient navigators will help patients recently hospitalized for heart f...

What is the current status of trial NCT02340364?

This trial is currently completed. It is a NA study. The enrollment target is 301 participants. The study started on 2015-03. Estimated completion is 2019-07.

What interventions are being tested in trial NCT02340364?

The interventions under investigation include: Education + Patient Navigation (BEHAVIORAL), Self-care Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT02340364?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.